logo

location icon
collection

Home Collection

04069467075

Get a call back from our health advisor

Bcr/abl Quantitative - Rt PCR (Philadelphia)

in Kolkata

Test Details

Test Overview

Test Inclusions

Why Apollo Diagnostics

package-details-page

BCR/ABL QUANTITATIVE - RT PCR (PHILADELPHIA)

BCR/ABL Quantitative RT PCR(Philadelphia) is a fusion gene which results from the rearrangement of BCR on chromosome 22 with the ABL on Chromosome 9. This leads to the formation of the Philadelphia chromosome and is found in 95% patients with CML. With the help of this quantitative test, doctors can manage and monitor the disease and its effect after therapy.

Test Overview

Understanding BCR-ABL and the Quantitative RT-PCR Test

Introduction to BCR-ABL (Philadelphia Chromosome)

The BCR-ABL fusion gene, commonly known as the Philadelphia chromosome, is a genetic mutation associated with certain types of leukaemia. This chromosomal abnormality arises from a translocation between chromosomes 9 and 22. During this translocation, parts of these chromosomes break off and switch places, resulting in a new, abnormal gene on chromosome 22, termed BCR-ABL. This fusion gene produces a tyrosine kinase protein that drives the uncontrolled proliferation of white blood cells, characteristic of leukaemia.

The presence of the Philadelphia chromosome is a hallmark of Chronic Myeloid Leukaemia (CML), a type of cancer that affects the blood and bone marrow. It can also be found in some cases of Acute Lymphoblastic Leukaemia (ALL) and, less commonly, Acute Myeloid Leukaemia (AML). The mutation leads to the overproduction of white blood cells that do not mature properly, disrupting normal blood cell production and function.

Symptoms and Causes of BCR-ABL (Philadelphia Chromosome)

Symptoms:

- Fatigue: Individuals may experience persistent tiredness due to decreased red blood cell production.

- Fever: Elevated body temperature often results from infections or the disease itself.

- Easy Bruising or Bleeding: Increased tendency to bruise or bleed is common due to low platelet counts.

- Weight Loss: Unexplained weight loss can occur without changes in diet or exercise.

- Bone Pain: Discomfort or pain in bones, particularly in the sternum or long bones, may be experienced.

- Enlarged Spleen or Liver: Swelling of these organs can lead to feelings of fullness or discomfort.

Causes:

- Genetic Mutation: The BCR-ABL fusion gene is caused by a specific chromosomal translocation between chromosomes 9 and 22. This genetic mutation is usually acquired during the formation of blood cells rather than inherited.

- Exposure to Radiation: High levels of radiation, such as those used in cancer treatment, can increase the risk of developing leukaemia.

- Chemical Exposure: Prolonged exposure to certain chemicals, especially those used in chemotherapy, may also contribute to the development of leukaemia.

Diagnostic Tests for BCR-ABL (Philadelphia Chromosome)

Diagnosing the BCR-ABL gene involves several tests:

- Bone Marrow Biopsy: This procedure involves taking a sample of bone marrow from the hip bone to look for abnormal cells and genetic mutations. It is a primary diagnostic tool for leukaemia.

- Blood Tests: Complete blood counts (CBC) help detect abnormal levels of white blood cells, red blood cells, and platelets, which can indicate leukaemia.

- Cytogenetic Analysis: This test examines the chromosomes in cells to identify the Philadelphia chromosome. It is crucial for confirming the presence of the BCR-ABL gene.

- Fluorescence In Situ Hybridisation (FISH): Utilises fluorescent probes to detect the BCR-ABL gene fusion in cells. This method is used to visually confirm the presence of the genetic abnormality.

The OS0179-BCR-ABL (Philadelphia) Quantitative RT-PCR Test

What is the OS0179-BCR-ABL (Philadelphia) Quantitative RT-PCR Test?

The OS0179-BCR-ABL (Philadelphia) Quantitative RT-PCR (Reverse Transcriptase Polymerase Chain Reaction) test is a sophisticated molecular diagnostic tool designed to detect and measure the BCR-ABL fusion gene. This test quantifies the amount of BCR-ABL mRNA (messenger RNA) in blood or bone marrow samples, providing critical insights into the level of leukaemia activity and the response to treatment.

Unlike qualitative tests that only confirm the presence of the BCR-ABL gene, the quantitative RT-PCR test measures the amount of abnormal mRNA. This quantitative data helps healthcare providers assess how well the disease is being managed and make informed decisions about treatment adjustments.

Who Should Get the OS0179-BCR-ABL (Philadelphia) Quantitative RT-PCR Test Done?

The OS0179-BCR-ABL Quantitative RT-PCR test is recommended for:

- Patients Diagnosed with CML: This test is essential for monitoring the disease’s progression and evaluating how well the current treatment regimen is working.

- Individuals with ALL or AML: For patients suspected of having the Philadelphia chromosome, this test helps confirm the diagnosis and guide treatment decisions.

- Treatment Monitoring: Patients undergoing treatment for leukaemia need regular testing to track changes in disease activity and adjust treatment plans accordingly.

- Assessment of Minimal Residual Disease (MRD): The test is used to detect small amounts of leukaemia that may not be visible with other diagnostic methods but can impact prognosis and treatment strategies.

What Does the OS0179-BCR-ABL (Philadelphia) Quantitative RT-PCR Test Measure?

The OS0179-BCR-ABL Quantitative RT-PCR test measures:

- BCR-ABL mRNA Levels: It quantifies the amount of abnormal mRNA produced by the BCR-ABL gene. Higher levels of this mRNA indicate greater disease activity.

- Disease Monitoring: By comparing current results with baseline levels, the test helps track the effectiveness of treatment and the progression of the disease.

- Treatment Efficacy: Helps in assessing how well the current therapy is working and guides adjustments to the treatment plan if necessary.

How to Prepare for the OS0179-BCR-ABL (Philadelphia) Quantitative RT-PCR Test?

Preparation for the OS0179-BCR-ABL Quantitative RT-PCR test typically involves:

- Sample Collection: The test requires a blood sample or, in some cases, a bone marrow sample. Your healthcare provider will give instructions on how to provide these samples.

- No Special Preparation: Generally, there are no specific dietary or fasting requirements before the test. However, you should follow any specific instructions given by your healthcare provider.

- Informing About Medications: Inform your healthcare provider about any medications you are taking, as some treatments may affect test results or interpretation.

In summary, the OS0179-BCR-ABL (Philadelphia) Quantitative RT-PCR test is a vital tool in the diagnosis and management of leukaemia associated with the Philadelphia chromosome. By quantifying the BCR-ABL gene expression, this test provides crucial information for monitoring disease progression and treatment efficacy, ultimately contributing to better patient outcomes and personalised treatment strategies.

Test(s) Included (8)

BCR-ABL (PHILADELPHIA) QUANTITATIVE RT - PCR (8)

  • Final result: BCR -ABL1 (IS) -Value
  • Major -p210(e14a2/e13a2)
  • Minor-p190(e1a2)
  • Micro-p230(e19a2)
  • ABL -copy number
  • [BCR -ABL/ABL] X 100 (NCN)
  • IS -Conversion Factor -Value
  • Type of transcript detected

Why Apollo Diagnostics

Apollo Diagnostics holds the distinction of being India's first laboratory to achieve ISO certification for logistics. This underscores the company's unwavering commitment to quality assurance with GRL lab (NABL & CAP accredited), backed by a team of highly trained professionals. With a vast network of over 1500+ diagnostic centres, strategically located across the country, Apollo Diagnostics processes over 10 million diverse tests every year, demonstrating its extensive reach and calibre. The company provides a comprehensive range of diagnostic services, encompassing a wide spectrum of tests, including those related to diabetes, heart health, kidney function, thyroid disorders, liver health, infertility and many more. The company's service portfolio encompasses a wide array of disciplines, including biochemistry, microbiology, serology, haematology, immunology, molecular, genomics and clinical pathology, among others.

BCR/ABL QUANTITATIVE - RT PCR (PHILADELPHIA)

₹7250

₹9667

25% off

Call to Book

PACKAGES

Top Booked Packages

icon

Xpert Health Basic - Kolkata

Home Collection Available

Report delivery-  Speak to our customer care

₹1599

₹2132

25% off

SAFE

icon

Xpert Health Comprehensive - Kolkata

Home Collection Available

Report delivery-  Speak to our customer care

₹3799

₹5065

25% off

SAFE

icon

Xpert Health Master check - Kolkata

Home Collection Available

Report delivery-  Speak to our customer care

₹2799

₹3732

25% off

SAFE

icon

Xpert Health Senior Citizen- Female

Home Collection Available

Report delivery-  Speak to our customer care

₹4299

₹5732

25% off

SAFE

icon

Xpert Health Senior Citizen- Male

Home Collection Available

Report delivery-  Speak to our customer care

₹4299

₹5732

25% off

SAFE

icon

Xpert Health Women Check

Home Collection Available

Report delivery-  Speak to our customer care

₹3499

₹4665

25% off

SAFE

icon

Xpert Vitamin Check

Home Collection Available

Report delivery-  Speak to our customer care

₹1699

₹2265

25% off

SAFE

Partner with us

Partnering with us offers entrepreneurs valuable mentoring, marketing guidance, and administrative support, paving the way for success.

For bulk test bookings, Reach out to us at:

customer.care@apollodiagnostics.in

Move To Top

Copyright © 2024 Apollo Diagnostics (Apollo Health and Lifestyle Limited), All Rights Reserved

Have a prescription ?

prescription icon

Call Us

04069467075

call icon